Attention Business Editors:

DXStorm Plans to Strengthen Medical Diagnostic Exchange through Partnership with Medical Insight A/S

TORONTO, March 4 /CNW/ - DXStorm Inc. ("DXStorm") (TSX Venture Exchange: DXX) today announced it has signed a Letter of Intent to form a partnership with Medical Insight A/S ("MI"), based in Denmark, which will significantly strengthen the medical imaging offering of Medical Diagnostics Exchange ("MDX").
Under the terms of the Letter of Intent, MDX has received exclusive Canadian and non-exclusive U.S. distribution rights to the MI flagship medical imaging solutions - Insight mPACs(TM) and Insight iRIS(TM) medical diagnostic imaging and workflow solutions.

With these MI solutions, hospitals and other health-care enterprises will have rapid organization-wide access to all patient 2D, 3D and 4D images and data. The Insight(TM) solution has been developed in concert with the ongoing daily evaluation and feedback of clinical radiologists and referring
physicians.
"We are pleased to introduce the breakthrough Insight(TM) PACS/RIS solution to the North American market,"" said Zoran Popovic, DXStorm CEO. "Given the similarities between the Canadian and Scandinavian healthcare systems, and the need to control escalating costs in the American healthcare system, we recognized that the Insight(TM) solution is a timely offering to the North American radiological community."

The unique MI Insight(TM) solution is based on a centralized scalable graphics server that can be accessed throughout an organization or over secure internet or intranet channels via workstations including ultra-thin clients, mobile clients, or existing computers. This provides quick and simple access to advanced and powerful visualization and analysis hardware, while specialized diagnostic applications (CAMs) provide focused clinical solutions.

With the Insight mPACS(TM) + Insight iRIS(TM) solution, health-care enterprises now have both rapid organization-wide and telemedicine access to all patient 2D, 3D, and 4D images and data.

Said Dr. Andy Dobbs, CEO of MI: "Seamless and brokerless integration of PACS and RIS functions is essential in today's market, especially for supporting and efficiently streamlining workflows across a medical enterprise. We are excited to partner with DXStorm with their range of networking, hosting and storage solutions and with MDX and the Galileo(TM) advanced medical imaging analysis solution."
Said Dr. Audrius Stundzia, Ph.D., MDX VP of Research and Development "Based on our market analysis, the Insight(TM) solution is the optimal PACS
and RIS platform for the Galileo(TM) advanced medical image analyst software. We are excited at this opportunity to offer to the North American market Advanced Biologic's Galileo(TM) medical image analysis solution in combination with PACS and diagnostic teleradiology using the proven capabilities of MI's Insight mPACS(TM) solution."
DXStorm owns 66.7% of MDX. The remaining 33.3% of MDX is owned by
Advanced Biologic Corp. ("Advanced Biologic"), a private company.

About DXStorm Inc.

DXStorm is a profitable E-Business Engineer and Service Provider.
Services from DXStorm include: E-Commerce Solutions for small-to-medium businesses, Network Services and Security, Enterprise Hosting and Co-location, Data storage for remote RIS/PACS and the Galileo(TM) Medical Image Analysis Software and Streaming Media. More information about DXStorm Inc. can be found on the Internet at http://www.dxstorm.com

About Medical Insight A/S.

Medical Insight A/S is a Danish company situated close to Copenhagen - in the medical research and development area known as Medicon Valley. The company's flagship product is Insight(TM) iRIS(TM) and Insight(TM) mPACS(TM). Medical Insight A/S is funded and owned by the management and Innfond, a Danish venture company. More information about Medical InSight A/S can be found at http://www.medical-insight.com.

Forward-Looking Statements

Any statements in this release that are not statements of fact may be
considered "forward looking statements" as that term is defined under
securities laws in Canada. Forward-looking statements are only predictions and may differ materially from actual events or results.

For further information: PLEASE CONTACT: DXStorm.com Inc., Zoran
Popovic, (905) 842-8262 ext 252, zoran@dxstorm.com

Medical Insight A/S, Andy Dobbs, Ph.D., +45 4050 9868,
abd@medical-insight.com; MDX Corp., Audrius Stundzia, Ph.D.,
(416) 247-7986, audrius@mdxcorp.com

	Galileo |  BrainGuide™
	Japan
	USA
	Canada
	Galileo | LungGuide™
	Japan
	USA

Please click-once to get a list of your specific institution or company.